Definitive Contract 75N91018C00023
Award Date 9/17/18
Potential Completion Date 2/15/21
Potential Value $300K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Vallejo, CA 94592, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
9
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Riptide Therapeutics LLC, a small business located in Evanston, Illinois, was awarded a $400,000 firm fixed-price contract by the National Cancer Institute on September 25, 2023, under the Small Business Innovation Research (SBIR) Program Topic 446 Phase I. The contract supports research and development activities focused on the development of senotherapeutic agents for cancer treatment, with an ultimate completion date of June 30, 2026. This award is designated as a total small business...
- This is a $355,000.00 Firm Fixed Price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Immunotarget Therapeutics Inc., a woman-owned small business. The contract is for the NCI's Small Business Innovation Research (SBIR) Innovative Concept Award program, which seeks proposals for highly innovative therapies, diagnostic tools, or preventive strategies focused on pediatric and/or rare cancers. The...
- This $399,987 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH), to Care Progress LLC, a small business limited liability company. The contract supports the development of cancer clinical trials recruitment and retention tools for participant engagement, as described in the original SBIR solicitation. The solicitation sought proposals for SBIR Phase I and Phase II contracts to conduct...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Detroit R&D, Inc., a minority-owned, economically disadvantaged, woman-owned small business. The contract is for R&D in biomedical basic research with a ceiling value of $299,097. The contract is a definitive, firm-fixed-price contract with a period of performance ending on September 21, 2016. This SBIR Phase I award will support the development of...
- <p>This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the National Cancer Institute (NCI), a civilian agency, to Sibtech, Inc., a for-profit manufacturer, in the amount of $2,256,052.35. The contract is for the development of systemic radionuclide therapy targeted to VEGF receptors in tumor vasculature. The contract has a firm fixed price pricing type and an ultimate completion date of October 31, 2021. This contract is a set-aside for small businesses.</p>
- This is a $300,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Base Pair Biotechnologies Inc., a for-profit company that provides custom aptamer development services and products to the federal government. The contract is for the "Development and Validation of Non-Mouse Reagents to Enable Preclinical Development of Novel Therapeutics", which was one of the research topics identified in the...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Radiologics, Inc., a for-profit organization. The contract, valued at $225,000.00, is for the development of FDA-compliant imaging informatics for cancer research under SBIR Topic 365. As a SBIR Phase I award, this contract is set aside for small businesses. The contract has a firm fixed price pricing type and was awarded on September 18, 2017, with...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Pact & Health LLC, a for-profit limited liability company located in Branford, Connecticut. The contract, awarded on September 11, 2019, has a potential value of $299,799.00 and is for the development of a versatile radiation-triggered phosphor platform for localized anti-cancer therapy. The contract is a...
- This is a $454,997 fixed-price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), to Ambay Immune Sensors And Controls, LLC, a woman-owned small business. The contract was awarded under the FY20 SBIR Phase I solicitation and is for the development of a "non-invasive, novel test to monitor biological response to radiotherapy" under Topic #400 - AMBAY RADI-SENSE. The contract...
- This is a Small Business Innovation Research (SBIR) Phase I Concept Award from the National Cancer Institute (NCI), a civilian agency, to Tippingpoint Biosciences, Inc., a woman-owned small business. The $355,000 firm-fixed-price contract is for research and development activities to demonstrate technical feasibility and proof-of-concept for the development of innovative and potentially transformative therapeutic, device, diagnostic, or digital health technologies targeting Pediatric Cancers...